Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: JACC Heart Fail. 2022 Mar 9;10(4):227–234. doi: 10.1016/j.jchf.2021.12.006

Table 3.

Hazard ratios (95% confidence interval) for initial and recurrent heart failure hospitalization according to randomized groups and race*

Black participants
 White participants
Sequence of heart
failure
hospitalization		 Active
Omega-3
Events/Total		 Omega-3
placebo
Events/Total		 Hazard Ratio
(95% CI)
p-value		 Active
Omega-3
Events/Total		 Omega-3
placebo
Events/Total		 Hazard Ratio
(95% CI)
p-value		 P interaction race x
omega-3 fatty acids
Initial 54/2538 62/2549 0.87 (0.60-1.25)   162/9035 168/8997 0.95 (0.77-1.18) 0.60
Recurrent ƚ 72/2621 109/2666 0.65 (0.49-0.88) 221/9265 243/9244 0.90 (0.75-1.08) 0.0497
*

All models adjusted for age, sex, and vitamin D assignment versus placebo

ƚ

Inclusive of 36 participants with prevalent heart failure at randomization